1-3 of 3
Paulo Lúcio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Vitro and in Vivo Targeting of Chronic Lymphocytic Leukemia Using CX-4945, a Clinical-Stage CK2-Specific Inhibitor.

Leila R. Martins, DVM, Paulo Lúcio, MD, PhD, Alice Melao, Bruno A. Cardoso, PhD, Ryan Stansfield, Denis Drygin, PhD, Maria Gomes Silva, MD, PhD, Joao T. Barata, PhD
Journal: Blood
Blood (2012) 120 (21): 2897.
https://doi.org/10.1182/blood.V120.21.2897.2897
Published: 2012
Journal Articles

Health Outcomes and Costs of Rituximab in Combination with Cyclophosphamide, Vincristine and Prednisolone in the Treatment of Patients with Advanced Follicular Lymphoma in Portugal.

Paula Braga, Susana Carvalho, Marília Gomes, Lurdes Guerra, Paulo Lúcio, Herlander Marques, Filipa Negreiro, Statistician, Catarina Pereira, Catarina Silva, Senior, Statistician, Adriana Teixeira
Journal: Blood
Blood (2009) 114 (22): 2481.
https://doi.org/10.1182/blood.V114.22.2481.2481
Published: 2009
Journal Articles

Targeting CK2 Overexpression as a Novel Therapeutic Tool in Chronic Lymphocytic Leukemia.

Leila R. Martins, Paulo Lúcio, MD, PhD, Paula Gameiro, MD, Maria Gomes Silva, MD, PhD, Joao T Barata, PhD
Journal: Blood
Blood (2009) 114 (22): 803.
https://doi.org/10.1182/blood.V114.22.803.803
Published: 2009